Disc Medicine Inc (IRON)
41.62
-4.85
(-10.44%)
USD |
NASDAQ |
Jul 02, 16:00
43.69
+2.07
(+4.97%)
After-Hours: 20:00
Disc Medicine Cash from Operations (Quarterly): -33.60M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -33.60M |
| December 31, 2023 | -17.80M |
| September 30, 2023 | -7.476M |
| June 30, 2023 | -12.72M |
| March 31, 2023 | -35.47M |
| December 31, 2022 | -9.665M |
| September 30, 2022 | -9.692M |
| June 30, 2022 | -9.194M |
| March 31, 2022 | -13.70M |
| Date | Value |
|---|---|
| December 31, 2021 | 19.50M |
| September 30, 2021 | -16.10M |
| June 30, 2021 | -15.93M |
| March 31, 2021 | -15.01M |
| December 31, 2020 | -8.853M |
| September 30, 2020 | -6.941M |
| June 30, 2020 | -7.033M |
| March 31, 2020 | -9.881M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.47M
Minimum
Mar 2023
19.50M
Maximum
Dec 2021
-12.33M
Average
-9.881M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 29.08M |
| Alnylam Pharmaceuticals Inc | -81.52M |
| Marinus Pharmaceuticals Inc | -37.46M |
| Rocket Pharmaceuticals Inc | -56.86M |
| Regenxbio Inc | -55.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.067M |
| Cash from Financing (Quarterly) | 15.90M |
| Free Cash Flow | -71.72M |
| Free Cash Flow Per Share (Quarterly) | -1.357 |
| Free Cash Flow Yield | -7.26% |